cached image

Bertha Madras - Publications

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Psychobiology
Website:
http://www.hms.harvard.edu/Academy/academy/members.html#m

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Di Raddo ME, Milenkovic M, Sivasubramanian M, Hasbi A, Bergman J, Withey S, Madras BK, George SR. Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults. Current Research in Neurobiology. 5: 100107. PMID 38020805 DOI: 10.1016/j.crneur.2023.100107  0.736
2021 Withey SL, Kangas BD, Charles S, Gumbert AB, Eisold JE, George SR, Bergman J, Madras BK. Effects of daily Δ-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates. Drug and Alcohol Dependence. 221: 108629. PMID 33640678 DOI: 10.1016/j.drugalcdep.2021.108629  0.708
2020 Hasbi A, Sivasubramanian M, Milenkovic M, Komarek K, Madras BK, George SR. Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration. Neurobiology of Disease. 105017. PMID 32679312 DOI: 10.1016/J.Nbd.2020.105017  0.313
2020 Withey SL, Bergman J, Huestis MA, George SR, Madras BK. THC and CBD blood and brain concentrations following daily administration to adolescent primates. Drug and Alcohol Dependence. 213: 108129. PMID 32593153 DOI: 10.1016/J.Drugalcdep.2020.108129  0.712
2020 Withey SL, Eisold JE, Chelini G, Kangas BD, Bergman J, Madras BK. Behavioral and Molecular Effects of THC and CBD in Adolescent Nonhuman Primates The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09462  0.702
2019 Hasbi A, Madras BK, Bergman J, Kohut S, Lin Z, Withey SL, George SR. Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. Iscience. 23: 100794. PMID 31972514 DOI: 10.1016/J.Isci.2019.100794  0.762
2015 Madras BK, Fischman AJ, Meltzer PC, Bonab AA. Drug scheduling of stimulants: Dopamine transporter effects, brain occupancy and abuse liability Drug and Alcohol Dependence. 156: e138. DOI: 10.1016/J.DRUGALCDEP.2015.07.377  0.321
2015 Madras BK, Zimmer J, Ogawa LM, Miller GM, Westmoreland SV, Vallender E, Hurd YL. THC (Δ9-tetrahydrocannabinol) elicits persistent changes in expression of genes implicated in adolescent neurodevelopment Drug and Alcohol Dependence. 146: e190. DOI: 10.1016/J.Drugalcdep.2014.09.432  0.658
2014 Madras BK, Vallender EJ, Walsh T, Miller GM, Westmoreland S. Dopamine systems in adolescent and adult brain respond differently to methamphetamine Drug and Alcohol Dependence. 140: e131. DOI: 10.1016/J.Drugalcdep.2014.02.374  0.713
2013 Miller GM, Madras BK, Xie Z. Trace Amine Associated Receptor 1 is a Catecholamine Receptor that Differentially Controls DAT and NET Internalization Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 48. DOI: 10.1016/B978-0-12-800044-1.00042-8  0.48
2011 Westmoreland SV, Annamalai L, Lentz MR, Ratai EM, Assaf B, Boisvert K, Huynh T, Vallender EJ, Miller GM, Madras BK, Gonzalez RG. Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques. Journal of Neurovirology. 17: 455-68. PMID 21789725 DOI: 10.1007/S13365-011-0047-0  0.657
2010 Spencer TJ, Madras BK, Bonab AA, Dougherty DD, Clarke A, Mirto T, Martin J, Fischman AJ. A positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [¹¹C]altropane and [¹¹C]raclopride. Biological Psychiatry. 68: 964-70. PMID 21035624 DOI: 10.1016/j.biopsych.2010.08.026  0.315
2008 Verrico CD, Lynch L, Fahey MA, Fryer AK, Miller GM, Madras BK. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. Journal of Psychopharmacology (Oxford, England). 22: 187-202. PMID 18308800 DOI: 10.1177/0269881107083639  0.714
2007 Xie Z, Westmoreland SV, Bahn ME, Chen GL, Yang H, Vallender EJ, Yao WD, Madras BK, Miller GM. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. The Journal of Pharmacology and Experimental Therapeutics. 321: 116-27. PMID 17234900 DOI: 10.1124/Jpet.106.116863  0.745
2007 Pham-Huu DP, Deschamps JR, Liu S, Madras BK, Meltzer PC. Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters. Bioorganic & Medicinal Chemistry. 15: 1067-82. PMID 17070057 DOI: 10.1016/j.bmc.2006.10.016  0.303
2007 Verrico CD, Miller GM, Madras BK. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology. 189: 489-503. PMID 16220332 DOI: 10.1007/S00213-005-0174-5  0.725
2006 Madras BK, Fahey MA, Goulet M, Lin Z, Bendor J, Goodrich C, Meltzer PC, Elmaleh DR, Livni E, Bonab AA, Fischman AJ. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. The Journal of Pharmacology and Experimental Therapeutics. 319: 570-85. PMID 16885433 DOI: 10.1124/Jpet.106.105312  0.719
2006 Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics. 319: 561-9. PMID 16885432 DOI: 10.1124/Jpet.106.106583  0.717
2006 Jassen AK, Yang H, Miller GM, Calder E, Madras BK. Receptor regulation of gene expression of axon guidance molecules: implications for adaptation. Molecular Pharmacology. 70: 71-7. PMID 16595738 DOI: 10.1124/Mol.105.021998  0.537
2006 Spencer TJ, Biederman J, Ciccone PE, Madras BK, Dougherty DD, Bonab AA, Livni E, Parasrampuria DA, Fischman AJ. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. The American Journal of Psychiatry. 163: 387-95. PMID 16513858 DOI: 10.1176/appi.ajp.163.3.387  0.305
2006 Meltzer PC, Butler D, Deschamps JR, Madras BK. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. Journal of Medicinal Chemistry. 49: 1420-32. PMID 16480278 DOI: 10.1021/jm050797a  0.313
2006 Xiao D, Miller GM, Jassen A, Westmoreland SV, Pauley D, Madras BK. Ephrin/Eph receptor expression in brain of adult nonhuman primates: implications for neuroadaptation. Brain Research. 1067: 67-77. PMID 16360648 DOI: 10.1016/J.Brainres.2005.10.073  0.593
2006 Anderson CM, Maas LC, Frederick Bd, Bendor JT, Spencer TJ, Livni E, Lukas SE, Fischman AJ, Madras BK, Renshaw PF, Kaufman MJ. Cerebellar vermis involvement in cocaine-related behaviors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1318-26. PMID 16237382 DOI: 10.1038/Sj.Npp.1300937  0.586
2005 Jassen AK, Brown JM, Panas HN, Miller GM, Xiao D, Madras BK. Variants of the primate vesicular monoamine transporter-2. Brain Research. Molecular Brain Research. 139: 251-7. PMID 15978697 DOI: 10.1016/J.Molbrainres.2005.05.028  0.516
2005 Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attention-deficit/hyperactivity disorder. Biological Psychiatry. 57: 1397-409. PMID 15950014 DOI: 10.1016/J.Biopsych.2004.10.011  0.566
2005 Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK. Primate trace amine receptor 1 modulation by the dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 313: 983-94. PMID 15764732 DOI: 10.1124/Jpet.105.084459  0.753
2005 Yatin SM, Miller GM, Madras BK. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation. Journal of Neuroscience Methods. 143: 69-78. PMID 15763138 DOI: 10.1016/J.Jneumeth.2004.09.016  0.582
2004 Meltzer PC, Pham-Huu DP, Madras BK. Synthesis of 8-thiabicyclo[3.2.1]oct-2-enes and their binding affinity for the dopamine and serotonin transporters. Bioorganic & Medicinal Chemistry Letters. 14: 6007-10. PMID 15546718 DOI: 10.1016/j.bmcl.2004.09.080  0.36
2004 Miller GM, Bendor J, Tiefenbacher S, Yang H, Novak MA, Madras BK. A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Molecular Psychiatry. 9: 99-108. PMID 14699447 DOI: 10.1038/Sj.Mp.4001378  0.493
2003 Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ. Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. European Journal of Pharmacology. 479: 41-51. PMID 14612136 DOI: 10.1016/J.Ejphar.2003.08.055  0.664
2003 Meltzer PC, McPhee M, Madras BK. Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes. Bioorganic & Medicinal Chemistry Letters. 13: 4133-7. PMID 14592523 DOI: 10.1016/j.bmcl.2003.07.014  0.345
2003 Meltzer PC, Wang P, Blundell P, Madras BK. Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate. Journal of Medicinal Chemistry. 46: 1538-45. PMID 12672255 DOI: 10.1021/jm0205292  0.332
2002 Meltzer PC, Liu S, Blanchette H, Blundell P, Madras BK. Design and synthesis of an irreversible dopamine-sparing cocaine antagonist. Bioorganic & Medicinal Chemistry. 10: 3583-91. PMID 12213473 DOI: 10.1016/S0968-0896(02)00244-4  0.355
2002 Yatin SM, Miller GM, Norton C, Madras BK. Dopamine transporter-dependent induction of C-Fos in HEK cells. Synapse (New York, N.Y.). 45: 52-65. PMID 12112414 DOI: 10.1002/Syn.10084  0.574
2002 Zhdanova IV, Geiger DA, Schwagerl AL, Leclair OU, Killiany R, Taylor JA, Rosene DL, Moss MB, Madras BK. Melatonin promotes sleep in three species of diurnal nonhuman primates. Physiology & Behavior. 75: 523-9. PMID 12062316 DOI: 10.1016/S0031-9384(02)00654-6  0.515
2002 Seeman P, Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behavioural Brain Research. 130: 79-83. PMID 11864721 DOI: 10.1016/S0166-4328(01)00435-1  0.418
2002 Madras BK, Miller GM, Fischman AJ. The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behavioural Brain Research. 130: 57-63. PMID 11864718 DOI: 10.1016/S0166-4328(01)00439-9  0.594
2002 Miller GM, Madras BK. Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Molecular Psychiatry. 7: 44-55. PMID 11803445 DOI: 10.1038/Sj.Mp.4000921  0.53
2001 Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, Madras BK. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates? Synapse (New York, N.Y.). 42: 129-40. PMID 11746710 DOI: 10.1002/Syn.1108  0.695
2001 Meltzer PC, Wang B, Chen Z, Blundell P, Jayaraman M, Gonzalez MD, George C, Madras BK. Synthesis of 6- and 7- hydroxy-8-azabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters. Journal of Medicinal Chemistry. 44: 2619-35. PMID 11472216 DOI: 10.1021/Jm0101242  0.332
2001 Miller GM, De La Garza R, Novak MA, Madras BK. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders. Molecular Psychiatry. 6: 50-8. PMID 11244485 DOI: 10.1038/Sj.Mp.4000809  0.52
2001 Miller GM, Yatin SM, De La Garza R, Goulet M, Madras BK. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Research. Molecular Brain Research. 87: 124-43. PMID 11223167 DOI: 10.1016/S0169-328X(00)00288-6  0.71
2001 Dutta AK, Reith ME, Madras BK. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter. Synapse (New York, N.Y.). 39: 175-81. PMID 11180505 DOI: 10.1002/1098-2396(200102)39:2<175::AID-SYN9>3.0.CO;2-W  0.312
2000 Madras BK, Miller GM, Meltzer PC, Brownell AL, Fischman AJ. Molecular and regional targets of cocaine in primate brain: liberation from prosaic views. Addiction Biology. 5: 351-9. PMID 20575852 DOI: 10.1111/J.1369-1600.2000.Tb00202.X  0.588
2000 Meltzer PC, Blundell P, Yong YF, Chen Z, George C, Gonzalez MD, Madras BK. 2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters. Journal of Medicinal Chemistry. 43: 2982-91. PMID 10956207 DOI: 10.1021/jm000191g  0.338
2000 Meltzer PC, Blundell P, Huang H, Liu S, Yong YF, Madras BK. 3-Aryl-2-carbomethoxybicyclo[3.2.1]oct-2-enes inhibit WIN 35,428 binding potently and selectively at the dopamine transporter. Bioorganic & Medicinal Chemistry. 8: 581-90. PMID 10732975 DOI: 10.1016/S0968-0896(99)00322-3  0.352
2000 Meschler JP, Clarkson FA, Mathews PJ, Howlett AC, Madras BK. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates. The Journal of Pharmacology and Experimental Therapeutics. 292: 952-9. PMID 10688609  0.318
2000 Goulet M, Madras BK. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys. The Journal of Pharmacology and Experimental Therapeutics. 292: 714-24. PMID 10640310  0.56
1999 De La Garza R, Meltzer PC, Madras BK. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain. Synapse (New York, N.Y.). 34: 20-7. PMID 10459168 DOI: 10.1002/(SICI)1098-2396(199910)34:1<20::AID-SYN3>3.0.CO;2-4  0.335
1999 Morris ED, Bonab AA, Alpert NM, Fischman AJ, Madras BK, Christian BT. Concentration of dopamine transporters: to Bmax or not to Bmax? Synapse (New York, N.Y.). 32: 136-40. PMID 10231133 DOI: 10.1002/(Sici)1098-2396(199905)32:2<136::Aid-Syn7>3.0.Co;2-G  0.317
1998 Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain. Synapse (New York, N.Y.). 29: 116-27. PMID 9593102 DOI: 10.1002/(Sici)1098-2396(199806)29:2<116::Aid-Syn3>3.0.Co;2-A  0.355
1998 Madras BK, Gracz LM, Meltzer PC, Liang AY, Elmaleh DR, Kaufman MJ, Fischman AJ. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain. Synapse (New York, N.Y.). 29: 105-15. PMID 9593101 DOI: 10.1002/(Sici)1098-2396(199806)29:2<105::Aid-Syn2>3.0.Co;2-B  0.627
1998 Madras BK, Meltzer PC, Liang AY, Elmaleh DR, Babich J, Fischman AJ. Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain. Synapse (New York, N.Y.). 29: 93-104. PMID 9593100 DOI: 10.1002/(SICI)1098-2396(199806)29:2<93::AID-SYN1>3.0.CO;2-5  0.364
1997 Meltzer PC, Liang AY, Blundell P, Gonzalez MD, Chen Z, George C, Madras BK. 2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters. Journal of Medicinal Chemistry. 40: 2661-73. PMID 9276012 DOI: 10.1021/Jm9703045  0.317
1997 Meltzer PC, Blundell P, Jones AG, Mahmood A, Garada B, Zimmerman RE, Davison A, Holman BL, Madras BK. A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain. Journal of Medicinal Chemistry. 40: 1835-44. PMID 9191960 DOI: 10.1021/jm960868t  0.341
1997 Fischman AJ, Babich JW, Elmaleh DR, Barrow SA, Meltzer P, Hanson RN, Madras BK. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 144-50. PMID 8998169  0.325
1996 Madras BK, Pristupa ZB, Niznik HB, Liang AY, Blundell P, Gonzalez MD, Meltzer PC. Nitrogen-based drugs are not essential for blockade of monoamine transporters. Synapse (New York, N.Y.). 24: 340-8. PMID 10638825 DOI: 10.1002/(SICI)1098-2396(199612)24:4<340::AID-SYN4>3.0.CO;2-D  0.313
1996 Elmaleh DR, Fischman AJ, Shoup TM, Byon C, Hanson RN, Liang AY, Meltzer PC, Madras BK. Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 37: 1197-202. PMID 8965198  0.337
1996 Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, Hsu H, Christian BT, Madras BK, Fischman AJ. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT. Synapse (New York, N.Y.). 24: 262-72. PMID 8923667 DOI: 10.1002/(Sici)1098-2396(199611)24:3<262::Aid-Syn9>3.0.Co;2-C  0.303
1996 Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 276: 942-50. PMID 8786574  0.524
1995 Gracz LM, Madras BK. [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum. The Journal of Pharmacology and Experimental Therapeutics. 273: 1224-34. PMID 7791095  0.306
1994 Meltzer PC, Liang AY, Madras BK. The discovery of an unusually selective and novel cocaine analog: difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. Journal of Medicinal Chemistry. 37: 2001-10. PMID 8027983  0.351
1994 Madras BK, Kaufman MJ. Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution. Synapse (New York, N.Y.). 18: 261-75. PMID 7855738 DOI: 10.1002/Syn.890180311  0.606
1993 Kaufman MJ, Madras BK. [3H]CFT ([3H]WIN 35,428) accumulation in dopamine regions of monkey brain: comparison of a mature and an aged monkey. Brain Research. 611: 322-5. PMID 8334525 DOI: 10.1016/0006-8993(93)90519-S  0.628
1993 Madras BK, Kaufman MJ. In vivo distribution of [3H](-)-cocaine in primate brain: Comparison with [3H]mazindol distribution Nida Research Monograph Series. 107.  0.537
1992 Kaufman MJ, Madras BK. Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI-55. Synapse (New York, N.Y.). 12: 99-111. PMID 1481136 DOI: 10.1002/Syn.890120203  0.607
1992 Rosenzweig-Lipson S, Bergman J, Spealman RD, Madras BK. Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites. Psychopharmacology. 107: 186-94. PMID 1377395 DOI: 10.1007/Bf02245136  0.491
1992 Spealman RD, Bergman J, Madras BK, Kamien JB, Melia KF. Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine. Neurochemistry International. 20: 147S-152S. PMID 1365414 DOI: 10.1016/0197-0186(92)90228-J  0.511
1991 Bergman J, Madras BK, Spealman RD. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 258: 910-7. PMID 1890625  0.462
1991 Kaufman MJ, Madras BK. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum. Synapse (New York, N.Y.). 9: 43-9. PMID 1796351 DOI: 10.1002/Syn.890090107  0.613
1991 Kaufman MJ, Spealman RD, Madras BK. Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT. Synapse (New York, N.Y.). 9: 177-87. PMID 1776130 DOI: 10.1002/Syn.890090304  0.584
1991 Spealman RD, Bergman J, Madras BK. Self-administration of the high-affinity cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. Pharmacology, Biochemistry, and Behavior. 39: 1011-3. PMID 1763097 DOI: 10.1016/0091-3057(91)90067-C  0.478
1991 Spealman RD, Bergman J, Madras BK, Melia KF. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 258: 945-53. PMID 1679852  0.504
1990 Canfield DR, Spealman RD, Kaufman MJ, Madras BK. Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain. Synapse (New York, N.Y.). 6: 189-95. PMID 2237780 DOI: 10.1002/Syn.890060211  0.58
1989 Spealman RD, Madras BK, Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. The Journal of Pharmacology and Experimental Therapeutics. 251: 142-9. PMID 2795456  0.503
1989 Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 251: 150-5. PMID 2529365  0.469
1981 Davis A, Madras B, Seeman P. Solubilization of neuroleptic/dopamine receptors of human brain striatum. European Journal of Pharmacology. 70: 321-9. PMID 6112153 DOI: 10.1016/0014-2999(81)90166-7  0.409
1975 Fernstrom JD, Hirsch MJ, Madras BK, Sudarsky L. Effects of skim milk, whole milk and light cream on serum tryptophan binding and brain tryptophan concentrations in rats. The Journal of Nutrition. 105: 1359-62. PMID 1159526 DOI: 10.1093/Jn/105.10.1359  0.445
1974 Madras BK, Cohen EL, Messing R, Munro HN, Wurtman RJ. Relevance of free tryptophan in serum to tissue tryptophan concentrations. Metabolism: Clinical and Experimental. 23: 1107-16. PMID 4427559 DOI: 10.1016/0026-0495(74)90027-4  0.529
1973 Lipsett D, Madras BK, Wurtman RJ, Munro HN. Serum tryptophan level after carbohydrate ingestion: selective decline in non-albumin-bound tryptophan coincident with reduction in serum free fatty acids. Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology. 12: 57-64. PMID 4707783 DOI: 10.1016/0024-3205(73)90027-1  0.337
1973 Madras BK, Cohen EL, Fernstrom JD, Larin F, Munro HN, Wurtman RJ. Letter: Dietary carbohydrate increases brain tryptophan and decreases free plasma tryptophan. Nature. 244: 34-5. PMID 4582482 DOI: 10.1038/244034A0  0.576
1969 Sourkes TL, Missala K, Madras BK. Effect of yohimbine on tryptophan metabolism. The Journal of Pharmacology and Experimental Therapeutics. 165: 289-93. PMID 5763063  0.411
1968 Madras BK, Sourkes TL. Formation of respiratory 14CO2 from variously labeled forms of tryptophan-14C in intact and adrenalectomized rats. Archives of Biochemistry and Biophysics. 125: 829-36. PMID 5671046 DOI: 10.1016/0003-9861(68)90521-3  0.425
1968 Madras BK, Sourkes TL. Effects of drugs on the metabolism of tryptophan. Alpha-hydrazinotryptophan and other amino acid analogs. Biochemical Pharmacology. 17: 1037-47. PMID 5301832 DOI: 10.1016/0006-2952(68)90362-6  0.445
1965 Madras BK, Sourkes TL. Metabolism of alpha-methyltryptophan. Biochemical Pharmacology. 14: 1499-506. PMID 5867505 DOI: 10.1016/0006-2952(65)90003-1  0.389
Show low-probability matches.